John Tchelingerian PhD

Dr. John Tchelingerian is a serial entrepreneur, an experienced leader, investor, and advisor in life sciences, biopharmaceuticals, diagnostics, digital health, and health tech interfaces. Before founding The Connecting Architects he co-founded and lead as CEO of several biotech companies, e.g. Neurotech, Key-Obs, Diatos, TcLand Expression, Key Neurosciences, Promethera Biosciences, and Melkin Pharmaceuticals.

John also originated, negotiated, and executed multiple M&A, licensing and R&D collaboration deals with US, EU, and Asian Biotech and pharmaceutical companies and is experienced in IPO and RTO processes on Euronext, Nasdaq, and Tokyo Stock Exchange. He raised a total of over €200 million from Venture Capital, Private Equity, and Strategic investors in Europe, the USA, Japan, Korea, and China.

John is chairman and non-executive director of several European life sciences companies. He is also an advisor to a leading European life sciences venture fund.

John has been an invited lecturer for biotech case studies and business models at INSEAD Business School in France. During his career, he invented several patents in the field of cell therapy and drug delivery.

John is a Ph.D. graduate in Neurosciences from Pierre et Marie Curie University (Paris, France) and a double winner of the 2019 CEO Today Global Awards and Global Business Awards.